Published in JAMA on September 19, 2001
Hydrogen Sulfide and Peripheral Arterial Disease | NCT01407172
The Chocolate Touch Study | NCT02924857
Prevention of Ischemic Events in Patients With Peripheral Arterial Disease (PID-PAB) | NCT00761969
Lifestyle Modification Programme for Patients With Peripheral Arterial Disease | NCT03935776
Optical Imaging Measurement of Intravascular Solution Efficacy Trial (OPTIMISE) | NCT01743872
Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2011) 31.98
Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2012) 30.79
Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation (2010) 30.07
Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2013) 28.02
The eMERGE Network: a consortium of biorepositories linked to electronic medical records data for conducting genomic studies. BMC Med Genomics (2011) 9.20
Leveraging informatics for genetic studies: use of the electronic medical record to enable a genome-wide association study of peripheral arterial disease. J Am Med Inform Assoc (2010) 4.33
Multifactorial determinants of functional capacity in peripheral arterial disease: uncoupling of calf muscle perfusion and metabolism. J Am Coll Cardiol (2009) 2.81
Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation (2017) 2.76
2011 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Peripheral Artery Disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2011) 2.71
Associations of borderline and low normal ankle-brachial index values with functional decline at 5-year follow-up: the WALCS (Walking and Leg Circulation Study). J Am Coll Cardiol (2009) 2.37
Statin use and lower extremity amputation risk in nonelderly diabetic patients. J Vasc Surg (2013) 2.05
Physical activity during daily life and mortality in patients with peripheral arterial disease. Circulation (2006) 2.02
Alternative ankle-brachial index method identifies additional at-risk individuals. J Am Coll Cardiol (2013) 1.86
Discovering peripheral arterial disease cases from radiology notes using natural language processing. AMIA Annu Symp Proc (2010) 1.86
Perioperative management with antiplatelet and statin medication is associated with reduced mortality following vascular surgery. J Vasc Surg (2014) 1.77
The effect of ezetimibe on peripheral arterial atherosclerosis depends upon statin use at baseline. Atherosclerosis (2011) 1.70
Baseline functional performance predicts the rate of mobility loss in persons with peripheral arterial disease. J Am Coll Cardiol (2007) 1.67
Peripheral artery disease: current insight into the disease and its diagnosis and management. Mayo Clin Proc (2010) 1.58
Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registry. Eur Heart J (2014) 1.55
Increased risk of vascular disease associated with gout: a retrospective, matched cohort study in the UK clinical practice research datalink. Ann Rheum Dis (2014) 1.54
Prevalence of peripheral arterial disease in high-risk patients using ankle-brachial index in general practice: a cross-sectional study. Int J Clin Pract (2009) 1.54
Automated ankle-brachial pressure index measurement by clinical staff for peripheral arterial disease diagnosis in nondiabetic and diabetic patients. Diabetes Care (2009) 1.53
Secondary prevention and mortality in peripheral artery disease: National Health and Nutrition Examination Study, 1999 to 2004. Circulation (2011) 1.51
Activating peripheral arterial disease patients to reduce cholesterol: a randomized trial. Am J Med (2011) 1.50
Usefulness of red cell distribution width to predict mortality in patients with peripheral artery disease. Am J Cardiol (2011) 1.42
Reproducibility and reliability of atherosclerotic plaque volume measurements in peripheral arterial disease with cardiovascular magnetic resonance. J Cardiovasc Magn Reson (2007) 1.40
A Randomized Controlled Trial of Allopurinol in Patients With Peripheral Arterial Disease. Can J Cardiol (2015) 1.40
Fear of movement/(re)injury and activity avoidance in persons with neurogenic versus vascular claudication. Spine J (2012) 1.39
Walking performance is positively correlated to calf muscle fiber size in peripheral artery disease subjects, but fibers show aberrant mitophagy: an observational study. J Transl Med (2016) 1.38
Adaptive changes in autogenous vein grafts for arterial reconstruction: clinical implications. J Vasc Surg (2009) 1.35
Delayed calf muscle phosphocreatine recovery after exercise identifies peripheral arterial disease. J Am Coll Cardiol (2006) 1.35
Associations between conventional cardiovascular risk factors and risk of peripheral artery disease in men. JAMA (2012) 1.29
Exercise rehabilitation in peripheral artery disease: functional impact and mechanisms of benefits. Circulation (2011) 1.27
Practice-based evidence: profiling the safety of cilostazol by text-mining of clinical notes. PLoS One (2013) 1.27
Risk factors, medical therapies and perioperative events in limb salvage surgery: observations from the PREVENT III multicenter trial. J Vasc Surg (2005) 1.26
Peripheral arterial disease: lack of awareness in Canada. Can J Cardiol (2009) 1.23
Exertional leg pain in patients with and without peripheral arterial disease. Circulation (2005) 1.22
Plasma levels of soluble Tie2 and vascular endothelial growth factor distinguish critical limb ischemia from intermittent claudication in patients with peripheral arterial disease. J Am Coll Cardiol (2008) 1.22
Atherosclerotic risk factor reduction in peripheral arterial diseasea: results of a national physician survey. J Gen Intern Med (2002) 1.19
Direct isolation, culture and transplant of mouse skeletal muscle derived endothelial cells with angiogenic potential. PLoS One (2008) 1.19
The morbidity and mortality following a diagnosis of peripheral arterial disease: long-term follow-up of a large database. BMC Cardiovasc Disord (2005) 1.18
Marvels, mysteries, and misconceptions of vascular compensation to peripheral artery occlusion. Microcirculation (2010) 1.18
Low lifetime recreational activity is a risk factor for peripheral arterial disease. J Vasc Surg (2011) 1.18
Limb stress-rest perfusion imaging with contrast ultrasound for the assessment of peripheral arterial disease severity. JACC Cardiovasc Imaging (2008) 1.15
Asymptomatic peripheral arterial disease is associated with more adverse lower extremity characteristics than intermittent claudication. Circulation (2008) 1.12
Exercise capacity is the strongest predictor of mortality in patients with peripheral arterial disease. J Vasc Surg (2012) 1.10
Angiogenesis in skeletal muscle precede improvements in peak oxygen uptake in peripheral artery disease patients. Arterioscler Thromb Vasc Biol (2011) 1.10
Long-term prognosis of diabetic patients with critical limb ischemia: a population-based cohort study. Diabetes Care (2009) 1.10
Skeletal muscle-specific genetic determinants contribute to the differential strain-dependent effects of hindlimb ischemia in mice. Am J Pathol (2012) 1.09
Genetic susceptibility to peripheral arterial disease: a dark corner in vascular biology. Arterioscler Thromb Vasc Biol (2007) 1.09
Dipyridamole enhances ischaemia-induced arteriogenesis through an endocrine nitrite/nitric oxide-dependent pathway. Cardiovasc Res (2010) 1.07
Profound influence of different methods for determination of the ankle brachial index on the prevalence estimate of peripheral arterial disease. BMC Public Health (2007) 1.06
Asymmetric dimethylarginine correlates with measures of disease severity, major adverse cardiovascular events and all-cause mortality in patients with peripheral arterial disease. Vasc Med (2010) 1.06
Ankle brachial index measurement in primary care: are we doing it right? Br J Gen Pract (2009) 1.06
Genetics of peripheral artery disease. Circulation (2012) 1.03
Peripheral arterial disease in the elderly. Clin Interv Aging (2007) 1.03
Incidence of noncardiac vascular disease in rheumatoid arthritis and relationship to extraarticular disease manifestations. Arthritis Rheum (2006) 1.02
Combined measurement of perfusion, venous oxygen saturation, and skeletal muscle T2* during reactive hyperemia in the leg. J Cardiovasc Magn Reson (2013) 1.02
A biomarker panel for peripheral arterial disease. Vasc Med (2008) 1.01
Putative mechanisms behind effects of spinal cord stimulation on vascular diseases: a review of experimental studies. Auton Neurosci (2008) 1.01
Combined effect of chronic kidney disease and peripheral arterial disease on all-cause mortality in a high-risk population. Clin J Am Soc Nephrol (2008) 1.01
Management of lower extremity peripheral arterial disease. J Cardiopulm Rehabil Prev (2008) 1.00
Billing code algorithms to identify cases of peripheral artery disease from administrative data. J Am Med Inform Assoc (2013) 1.00
Assessment of functional status and quality of life in claudication. J Vasc Surg (2011) 0.98
Bone marrow alterations and lower endothelial progenitor cell numbers in critical limb ischemia patients. PLoS One (2013) 0.98
Biomarkers of peripheral arterial disease. J Am Coll Cardiol (2010) 0.98
The prevalence and predictors of an abnormal ankle-brachial index in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial. Diabetes Care (2011) 0.98
Targeted screening for peripheral arterial disease in general practice: a pilot study in a high risk group. Br J Gen Pract (2007) 0.96
Peripheral arterial calcification: prevalence, mechanism, detection, and clinical implications. Catheter Cardiovasc Interv (2014) 0.94
Risk factor profile, management and prognosis of patients with peripheral arterial disease with or without coronary artery disease: results of the prospective German REACH registry cohort. Clin Res Cardiol (2009) 0.94
Diabetic neuropathy in older adults. Clin Geriatr Med (2008) 0.94
Adeno-associated virus serotype 9 efficiently targets ischemic skeletal muscle following systemic delivery. Gene Ther (2013) 0.93
Effects of a home-based walking intervention on mobility and quality of life in people with diabetes and peripheral arterial disease: a randomized controlled trial. Diabetes Care (2011) 0.93
Invasively-treated incidence of lower extremity peripheral arterial disease and associated factors in Taiwan: 2000-2011 nationwide hospitalized data analysis. BMC Public Health (2013) 0.93
Association of polymorphisms in NOS3 with the ankle-brachial index in hypertensive adults. Atherosclerosis (2007) 0.92
Incident physical disability in people with lower extremity peripheral arterial disease: the role of cardiovascular disease. J Am Geriatr Soc (2008) 0.91
Comparison between oscillometric- and Doppler-ABI in elderly individuals. Vasc Health Risk Manag (2013) 0.91
Peripheral artery disease assessed by ankle-brachial index in patients with established cardiovascular disease or at least one risk factor for atherothrombosis--CAREFUL study: a national, multi-center, cross-sectional observational study. BMC Cardiovasc Disord (2011) 0.90
The ankle-brachial index is associated with the magnitude of impaired walking endurance among men and women with peripheral arterial disease. Vasc Med (2010) 0.90
Peripheral arterial occlusive disease: magnetic resonance imaging and the role of aggressive medical management. World J Surg (2007) 0.90
Exercise training and peripheral arterial disease. Compr Physiol (2012) 0.90
Nonenhanced methods for lower-extremity MRA: a phantom study examining the effects of stenosis and pathologic flow waveforms at 1.5T. J Magn Reson Imaging (2011) 0.89
Multiparametric assessment of vascular function in peripheral artery disease: dynamic measurement of skeletal muscle perfusion, blood-oxygen-level dependent signal, and venous oxygen saturation. Circ Cardiovasc Imaging (2015) 0.89
Contemporary risk factor control and walking dysfunction in individuals with peripheral arterial disease: NHANES 1999-2004. Atherosclerosis (2008) 0.89
Targets and delivery methods for therapeutic angiogenesis in peripheral artery disease. Vasc Med (2012) 0.89
n-3 Polyunsaturated fatty acids supplementation in peripheral artery disease: the OMEGA-PAD trial. Vasc Med (2013) 0.89
Critical review of the ankle brachial index. Curr Cardiol Rev (2008) 0.89
Peripheral arterial disease of the lower extremities. Arch Med Sci (2012) 0.89
Brachial-ankle pulse wave velocity is associated with walking distance in patients referred for peripheral arterial disease evaluation. Atherosclerosis (2009) 0.89
Prevalence of peripheral arterial disease in patients at non-high cardiovascular risk. Rationale and design of the PANDORA study. BMC Cardiovasc Disord (2010) 0.88
Leg symptom categories and rates of mobility decline in peripheral arterial disease. J Am Geriatr Soc (2010) 0.88
The reliability of toe systolic pressure and the toe brachial index in patients with diabetes. J Foot Ankle Res (2010) 0.88
Whole-body MR vascular screening detects unsuspected concomitant vascular disease in coronary heart disease patients. Eur Radiol (2006) 0.88
The accuracy of the physical examination for the detection of lower extremity peripheral arterial disease. Can J Cardiol (2010) 0.88
Critical Limb Ischemia: Current Trends and Future Directions. J Am Heart Assoc (2016) 0.87
Outcomes for clinical studies assessing drug and revascularization therapies for claudication and critical limb ischemia in peripheral artery disease. Circulation (2013) 0.87
Lower extremity manifestations of peripheral artery disease: the pathophysiologic and functional implications of leg ischemia. Circ Res (2015) 0.87
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg (2007) 14.17
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg (2006) 10.79
Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA (2008) 7.84
The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension. N Engl J Med (1998) 7.18
Recruitment for controlled clinical trials: literature summary and annotated bibliography. Control Clin Trials (1997) 5.67
Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol (1995) 5.26
Differences between respondents and non-respondents in a population-based cardiovascular disease study. Am J Epidemiol (1978) 3.90
Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment. JAMA (2001) 3.90
Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation (1993) 3.54
Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation (1987) 3.49
Recruitment experience in clinical trials: literature summary and annotated bibliography. Control Clin Trials (1987) 3.39
Lower ankle/brachial index, as calculated by averaging the dorsalis pedis and posterior tibial arterial pressures, and association with leg functioning in peripheral arterial disease. J Vasc Surg (2000) 3.33
Increasing autistic children's spontaneous verbalizations of affection: an assessment of time delay and peer modeling procedures. J Appl Behav Anal (1986) 3.22
Primary prevention of coronary heart disease: guidance from Framingham: a statement for healthcare professionals from the AHA Task Force on Risk Reduction. American Heart Association. Circulation (1998) 3.18
Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. PREVENT Investigators. Circulation (2000) 2.96
Does childhood personality predict longevity? J Pers Soc Psychol (1993) 2.95
Prevention Conference V: Beyond secondary prevention: identifying the high-risk patient for primary prevention: noninvasive tests of atherosclerotic burden: Writing Group III. Circulation (2000) 2.94
The prevalence of peripheral arterial disease in a defined population. Circulation (1985) 2.88
Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group. Circulation (1994) 2.84
Physical fitness as a predictor of cardiovascular mortality in asymptomatic North American men. The Lipid Research Clinics Mortality Follow-up Study. N Engl J Med (1988) 2.84
Reduction of polygalacturonase activity in tomato fruit by antisense RNA. Proc Natl Acad Sci U S A (1988) 2.75
Endothelium-derived nitric oxide regulates arterial elasticity in human arteries in vivo. Hypertension (2001) 2.69
Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus. J Am Coll Cardiol (1996) 2.64
Dietary vitamin D and calcium and risk of colorectal cancer: a 19-year prospective study in men. Lancet (1985) 2.62
Estrogen use and all-cause mortality. Preliminary results from the Lipid Research Clinics Program Follow-Up Study. JAMA (1983) 2.57
Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial. J Vasc Surg (2010) 2.52
The logistic modeling of sensitivity, specificity, and predictive value of a diagnostic test. J Clin Epidemiol (1992) 2.52
The fallacy of employing standardized regression coefficients and correlations as measures of effect. Am J Epidemiol (1986) 2.50
Exercise training improves functional status in patients with peripheral arterial disease. J Vasc Surg (1996) 2.48
Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo. Circulation (1998) 2.38
Effect of a lifestyle intervention on change in cardiorespiratory fitness in adults with type 2 diabetes: results from the Look AHEAD Study. Int J Obes (Lond) (2009) 2.32
Correlation between preoperative ischemia and major cardiac events after peripheral vascular surgery. N Engl J Med (1989) 2.28
Exercise patterns in a population of older adults. Am J Prev Med (1989) 2.28
Structure and expression of elongation factor 1 alpha in tomato. Nucleic Acids Res (1989) 2.28
Effects of passive smoking on ischemic heart disease mortality of nonsmokers. A prospective study. Am J Epidemiol (1985) 2.12
Preprocedural risk stratification: identifying an appropriate population for carotid stenting. J Vasc Surg (2001) 2.11
Flow-induced vasodilation of the human brachial artery is impaired in patients <40 years of age with coronary artery disease. Am J Cardiol (1996) 2.09
The role of carnitine and carnitine supplementation during exercise in man and in individuals with special needs. J Am Coll Nutr (1998) 2.09
Arginine restores cholinergic relaxation of hypercholesterolemic rabbit thoracic aorta. Circulation (1991) 2.07
Long-term effects on clinical outcomes of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation in the post coronary artery bypass graft trial. Post CABG Investigators. Circulation (2000) 2.07
Postischemic vasodilation in human forearm is dependent on endothelium-derived nitric oxide. Am J Physiol (1996) 2.06
Aging progressively impairs endothelium-dependent vasodilation in forearm resistance vessels of humans. Hypertension (1996) 2.03
Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans. Circulation (1997) 2.00
Sociodemographic and psychosocial factors in childhood as predictors of adult mortality. Am J Public Health (1995) 1.98
The efficacy and six-week tolerability of simvastatin 80 and 160 mg/day. Am J Cardiol (1997) 1.98
Nitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humans. Circulation (1994) 1.96
Safety and efficacy of thrombolytic therapy for superior vena cava syndrome. Chest (1991) 1.90
Effects of thiazide diuretics on plasma lipids and lipoproteins in mildly hypertensive patients: a double-blind controlled trial. Ann Intern Med (1981) 1.89
Development of children's concepts of illness. Pediatrics (1980) 1.87
Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. J Clin Invest (1996) 1.86
Isolation and characterization of the human MRE11 homologue. Genomics (1995) 1.83
Response bias and risk ratios in epidemiologic studies. Am J Epidemiol (1979) 1.81
Lipoproteins as mediators for the effects of alcohol consumption and cigarette smoking on cardiovascular mortality: results form the Lipid Research Clinics Follow-up Study. Am J Epidemiol (1987) 1.81
Cardiovascular benefits and assessment of physical activity and physical fitness in adults. Med Sci Sports Exerc (1992) 1.81
The emerging role of statins in the prevention of coronary heart disease. BMJ (1997) 1.80
Results of language for health: cardiovascular disease nutrition education for Latino English-as-a-second-language students. Health Educ Behav (2000) 1.77
High density lipoprotein cholesterol as a predictor of cardiovascular disease mortality in men and women: the follow-up study of the Lipid Research Clinics Prevalence Study. Am J Epidemiol (1990) 1.76
Clinical trials for claudication. Assessment of exercise performance, functional status, and clinical end points. Vascular Clinical Trialists. Circulation (1995) 1.74
The effect of response bias on the odds ratio. Am J Epidemiol (1981) 1.73
Prevention of the Wernicke-Korsakoff syndrome: a cost-benefit analysis. N Engl J Med (1978) 1.73
A single amino acid substitution in the enzyme 5-enolpyruvylshikimate-3-phosphate synthase confers resistance to the herbicide glyphosate. J Biol Chem (1985) 1.72
Ischemic heart disease risk factors after age 50. J Chronic Dis (1984) 1.69
Venous severity scoring: An adjunct to venous outcome assessment. J Vasc Surg (2000) 1.68
Association between systemic calcified atherosclerosis and bone density. Calcif Tissue Int (2007) 1.67
Use of enoxaparin, a low-molecular-weight heparin, and unfractionated heparin for the prevention of deep venous thrombosis after elective hip replacement. A clinical trial comparing efficacy and safety. Enoxaparin Clinical Trial Group. J Bone Joint Surg Am (1994) 1.62
Adherence to screening mammography recommendations in a university general medicine clinic. J Gen Intern Med (1995) 1.61
Benefit of exercise conditioning for patients with peripheral arterial disease. Circulation (1990) 1.60
Impaired chronotropic response to exercise in patients with congestive heart failure. Role of postsynaptic beta-adrenergic desensitization. Circulation (1989) 1.60
Measuring physical activity in peripheral arterial disease: a comparison of two physical activity questionnaires with an accelerometer. Angiology (2000) 1.57
L-arginine augments endothelium-dependent vasodilation in cholesterol-fed rabbits. Circ Res (1990) 1.55
Psychosocial and behavioral predictors of longevity. The aging and death of the "termites". Am Psychol (1995) 1.54
Dihydroergotamine/heparin in the prevention of deep-vein thrombosis after total hip replacement. A controlled, prospective, randomized multicenter trial. J Bone Joint Surg Am (1988) 1.53
The sensitivity, specificity, and predictive value of traditional clinical evaluation of peripheral arterial disease: results from noninvasive testing in a defined population. Circulation (1985) 1.52
Blood pressure reductions with exercise and sodium restriction in postmenopausal women with elevated systolic pressure: role of arterial stiffness. J Am Coll Cardiol (2001) 1.52
AHA consensus panel statement. Preventing heart attack and death in patients with coronary disease. The Secondary Prevention Panel. J Am Coll Cardiol (1995) 1.52
Beta adrenergic-mediated vasodilator response to insulin in the human forearm. J Pharmacol Exp Ther (1985) 1.52
Building a research career in general internal medicine: a perspective from young investigators. J Gen Intern Med (1998) 1.50
Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women. Ann Intern Med (1994) 1.48
Fibromuscular dysplasia. Curr Opin Rheumatol (2000) 1.48
Breath alcohol analysis in the Accident and Emergency Department. Injury (1983) 1.47
Hospital vs home-based exercise rehabilitation for patients with peripheral arterial occlusive disease. Angiology (1997) 1.47
Effect of an aggressive lipid-lowering strategy on progression of atherosclerosis in the left main coronary artery from patients in the post coronary artery bypass graft trial. Circulation (2001) 1.46
Childhood conscientiousness and longevity: health behaviors and cause of death. J Pers Soc Psychol (1995) 1.45
Alcohol consumption and blood pressure. The lipid research clinics prevalence study. Hypertension (1982) 1.44
Abnormal oxygen uptake kinetic responses in women with type II diabetes mellitus. J Appl Physiol (1985) (1998) 1.43
Chronic changes in skeletal muscle histology and function in peripheral arterial disease. Circulation (1993) 1.43
The Toledo Exercise and Diet Study. Results at 26 weeks. Arch Intern Med (1990) 1.41
Superiority of treadmill walking exercise versus strength training for patients with peripheral arterial disease. Implications for the mechanism of the training response. Circulation (1994) 1.41
Diabetes and hypertension in a community of older adults. Am J Epidemiol (1981) 1.41
Screening for peripheral arterial disease: the sensitivity, specificity, and predictive value of noninvasive tests in a defined population. Am J Epidemiol (1994) 1.41
Serum immunoglobulin E after myocardial infarction. Circulation (1988) 1.40
Inter-society consensus for the management of peripheral arterial disease. Int Angiol (2007) 1.39
Factors influencing the development of hypercholesterolemia after cardiac transplantation. Am J Cardiol (1992) 1.39
Familial occurrence of neurocardiogenic syncope. N Engl J Med (1994) 1.39
Do non-scientists really live longer? Lancet (1994) 1.39